Siobhan Malany

Associate Professor University of Florida

  • Gainesville FL

Siobhan Malany studies the effects of microgravity on human muscle biology using an automated tissue chip system.

Contact

University of Florida

View more experts managed by University of Florida

Biography

Siobhan Malany's research seeks to implement improved in vitro cell-based systems to better predict human drug efficacy, particularly for muscle diseases. Her lab has developed a microphysiological system -- also referred to as a “tissue chip” -- to study age-related muscle wasting (sarcopenia). The lab is using patient-specific muscle primary cells in 3D culture integrated into a microfluidic device that was sent to the International Space Station research laboratory in 2020. Another experiment will be sent in 2022 to serve as a micro-scale model for studying physical changes induced in microgravity that may mimic aging and for predictive drug and toxicology testing to aide in the development of therapeutics for sarcopenia. She is a member of the Astraeus Space Institute.

Areas of Expertise

Space
Age-related Msucle Atrophy
Drug Discovery and Screening
Space Medicine
Human Muscle Biology
Tissue chips
Receptor Pharmacology

Media Appearances

'Space-Age' Research

UF Department of Pharmacy  online

2021-04-15

Second-by-second the countdown clock ticks down. It’s December 6, and Siobhan Malany, Ph.D., and a team of two dozen scientists, engineers and implementation partners have gathered on a causeway inside Kennedy Space Center to watch the launch of SpaceX’s Falcon 9 rocket. More than 6,500 pounds of research and supplies are on board the cargo capsule destined for the International Space Station, or ISS, including a lab-on-a-chip experiment from the University of Florida College of Pharmacy.

View More

Experiment launching from Space Coast to study muscle loss in space

WFTV 9  tv

2020-12-04

An out of this world mission may help University of Florida researchers understand why adults lose muscle strength as we age. The experiment will be inside the rocket scheduled to launch from the Kennedy Space Center on Saturday.

View More

Wisdom From The Women Leading the Space Industry, With Dr. Siobhan Malany, founder and president of Micro-gRx

Medium  online

2020-08-17

As a part of my series about “Women Leading the Space Industry,” I had the pleasure of interviewing Dr. Siobhan Malany, founder and president of Micro-gRx.

View More

Show All +

Articles

Biomanufacturing in low Earth orbit for regenerative medicine

International Society for Stem Cell Research

Arun Sharma, et al.

2021-12-30

Research in low Earth orbit (LEO) has become more accessible. The 2020 Biomanufacturing in Space Symposium reviewed space-based regenerative medicine research and discussed leveraging LEO to advance biomanufacturing for regenerative medicine applications. The symposium identified areas where financial investments could stimulate advancements overcoming technical barriers. Opportunities in disease modeling, stem-cell-derived products, and biofabrication were highlighted. The symposium will initiate a roadmap to a sustainable market for regenerative medicine biomanufacturing in space.

View more

Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators

PNAS

S. Jeson Sangaralingham, et al.

2021-12-20

The particulate guanylyl cyclase A receptor (GC-A), via its endogenous cardiac-derived hormones atrial natriuretic peptide (ANP) and b-type natriuretic peptide (BNP), plays a pivotal role in maintaining intravascular volume, arterial pressure, cardiovascular structure, function, and, more recently, metabolic homeostasis. As such, therapies to potentiate GC-A signaling via peptide augmentation have yielded promising results in clinical trials. A major breakthrough in GC-A therapeutics would be a small molecule that sensitizes the GC-A receptor to endogenous ANP or BNP, which to date does not exist.

View more

Discovery of small molecule antagonists of chemokine receptor CXCR6 that arrest tumor growth in SK-HEP-1 mouse xenografts as a model of hepatocellular carcinoma

Bioorganic & Medicinal Chemistry Letters

Satyamaheshwar Peddibhotla, et al.

2020-02-15

The chemokine system plays an important role in mediating a proinflammatory microenvironment for tumor growth in hepatocellular carcinoma (HCC). The CXCR6 receptor and its natural ligand CXCL16 are expressed at high levels in HCC cell lines and tumor tissues and receptor expression correlates with increased neutrophils in these tissues contributing to poor prognosis in patients.

View more

Media

Spotlight

3 min

UF scientist studies muscle loss in space to benefit astronauts and patients on Earth

Astronauts traveling to Mars will face many challenges, but one of the most serious is muscle loss during long space missions. A new study led by University of Florida researcher Siobhan Malany, Ph.D., sheds light on how human biology changes in microgravity and could help protect astronaut health while also offering hope for patients with muscle-wasting diseases on Earth. Malany, an associate professor in the College of Pharmacy, a member of UF’s Astraeus Space Institute, and director of the in-space Biomanufacturing Innovation Hub, recently published findings showing how muscle cells adapt in space. Her team studied bioengineered three-dimensional muscle tissues derived from biopsy cells from both younger and older individuals and observed how they responded to electrical stimulation in microgravity. These micro-scale tissues called “tissue chips” were given nutrients and electric pulses autonomously in a miniature laboratory the size of a shoe box called a CubeLab.x. A camera system inside the box recorded the rate of muscle contraction. “This research is about more than just space,” Malany said. “By understanding how muscle tissue deteriorates much faster in microgravity, we can uncover new strategies to address muscle loss that occurs naturally with aging and with age-related diseases here on Earth.” Siobhan Malany studies the effects of microgravity on human muscle biology using an automated tissue chip system. View her profile here The study found that younger muscle tissue showed more pronounced changes in mitochondrial pathways — cellular systems that produce energy — than older tissue did when exposed to microgravity. Researchers also discovered that, on Earth, older muscle tissue responds less to electrical stimulation than younger tissue. But in space, the younger tissue showed a noticeable drop in its ability to contract, suggesting that younger muscle may experience a greater change when exposed to the space environment. These insights may help researchers design new treatments to protect muscles in astronauts during long missions, as well as develop therapies for people experiencing age-related muscle loss on Earth. The project was part of UF’s broader efforts to advance space biology. Through the Astraeus Space Institute, UF brings together experts across disciplines, from medicine and pharmacy to engineering and plant science, to address the unique challenges of space exploration. “UF researchers are helping lay the groundwork for humanity’s next giant leap,” Malany said. “It’s exciting to see our work contribute to both the health of astronauts and the lives of patients back home.” UF’s leadership in space biology is strengthened through collaboration with partners including the Kennedy Space Center Consortium and the Center for Science, Technology and Advanced Research in Space), both initiatives bringing together universities in Florida’s high-tech corridor, government agencies and industry leaders. Malany’s work also builds on long-term collaborations with AdventHealth, using donated tissue samples to model age-related muscle changes in space. Her team also works with SpaceTango, a NASA-certified aerospace company, to design the CubeLab that flew to the International Space Station on multiple SpaceX missions. Looking ahead, Malany and her team are developing new ways to study astronaut-derived cells, including both skeletal and heart muscle, generated from blood samples. These “avatars” could help researchers track changes before, during and after space missions, providing an unprecedented window into how microgravity affects the human body. “Now we can study cells from individual astronauts and see how they respond over time,” Malany said. “This helps us understand the risks of long-term spaceflight and also gives us a platform for testing potential treatments for muscle-wasting conditions on Earth.” By using tissue chips, small, bioengineered devices that mimic the structure and function of human organs, scientists in space can gather data more quickly and accurately than with traditional animal studies, potentially accelerating the discovery of therapies for aging-related muscle loss. Looking to know more about this amazing research or connect with Siobhan Malany simply click on her icon now to arrange an interview today.

Siobhan Malany